The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX